Changes in Paracrine Interleukin-2 Requirement, CCR7 Expression, Frequency, and Cytokine Secretion of Human Immunodeficiency Virus-Specific CD4+T Cells Are a Consequence of Antigen Load
Open Access
- 15 March 2007
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 81 (6) , 2713-2725
- https://doi.org/10.1128/jvi.01830-06
Abstract
Virus-specific CD4+T-cell responses are thought to be required for the induction and maintenance of many effective CD8+T-cell and B-cell immune responses in experimental animals and humans. Although the presence of human immunodeficiency virus (HIV)-specific CD4+T cells has been documented in patients at all stages of HIV infection, many fundamental questions regarding their frequency and function remain. A 10-color, 12-parameter flow cytometric panel was utilized to examine the frequency, memory phenotype (CD27, CCR7, and CD45RA), and cytokine production (interleukin-2 [IL-2], gamma interferon, and tumor necrosis factor alpha) of CD4+T cells specific for HIV antigens as well as for adenovirus, Epstein-Barr virus (EBV), influenza H1N1 virus, influenza H3N2 virus, cytomegalovirus, varicella-zoster virus (VZV), and tetanus toxoid in normal controls, long-term nonprogressors (LTNP), and HIV-infected patients with progressive disease on or off therapy. The HIV-specific CD4+T-cell responses in LTNP and patients on therapy were similar in frequency, phenotype, and cytokine production to responses directed against adenovirus, EBV, influenza virus, and VZV. HIV-specific CD4+T cells from patients off antiretroviral therapy demonstrated a shift towards a CCR7−CD45RA−phenotype and a reduced percentage of IL-2-producing cells. The alterations in cytokine production during HIV viremia were found to be intrinsic to the HIV-specific CD4+T cells and caused a requirement for IL-2 supplied exogenously for proliferation to occur. These observations suggest that many previously described changes in HIV-specific CD4+T-cell function and phenotype are a consequence of high levels of antigen in viremic patients. In addition, defects in function and phenotype of HIV-specific CD4+T cells are not readily discernible in the context of antiretroviral therapy but rather are similar to responses to other viruses.Keywords
This publication has 56 references indexed in Scilit:
- PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progressionNature, 2006
- Preferential Infection Shortens the Life Span of Human ImmunodeficiencyVirus-Specific CD4+T Cells In VivoJournal of Virology, 2006
- Limited Durability of Viral Control following Treated Acute HIV InfectionPLoS Medicine, 2004
- HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative CapacityThe Journal of Experimental Medicine, 2003
- Discontinuation of Antiretroviral Therapy Commenced Early during the Course of Human Immunodeficiency Virus Type 1 Infection, with or without Adjunctive VaccinationThe Journal of Infectious Diseases, 2002
- PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2European Journal of Immunology, 2002
- Proliferative Responses to Human Immunodeficiency Virus Type 1 (HIV‐1) Antigens in HIV‐1–Infected Patients with Immune ReconstitutionThe Journal of Infectious Diseases, 2001
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Mechanisms of Immunosuppression in Cytomegalovirus Mononucleosis. II. Virus-Monocyte InteractionsThe Journal of Infectious Diseases, 1981
- Cell-Mediated Immunity during Natural Measles InfectionJournal of Clinical Investigation, 1978